Article info
PDFLetter
Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Citation
Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Publication history
- First published August 1, 2002.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the Journal of Medical Ethics
Other content recommended for you
- Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
- Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
- Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania
- Spurious and counterfeit drugs: a growing industry in the developing world
- Evaluation of the decision-making process underlying the initial off-label use of vaccines: a scoping review protocol
- Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers
- Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines
- Unlicensed and off label drug use in paediatric wards: prospective study
- Unlicensed and off label drug use in neonates
- Off-label use of bevacizumab in the treatment of retinal disease: ethical implications